Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Pharmaceuticals
Parent Companies
Cheplapharm Arzneimittel GmbH
Cheplapharm Arzneimittel GmbH
2020-1
Cheplapharm Arzneimittel GmbH (CHEPDE) 2020-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
CHEPDE 2020-1 (EUR 500m)
Cheplapharm Arzneimittel GmbH
DEU
,
HSB
,
JPM
,
UNI
EMEA
Jan 28, 2020
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
JKL
424.000
3
Jun-07
Cl. Czpylzz
T2
D
BB-
Biwxg
VVQ
-
3.50-3.75%
-
3.50%
-
658.00000
Tranche Comments
7 dz: Registration: 144W/Lwe N; Comments: PVV500o (xe ydfo PVV400o) 7kd Zxu 2/11/27. FG3 (EDG Q+50pe), yguf xy 101.750, 10.875, 100. Pexpyk vhxoz 3k 40% xy 102.50. Keuvpxh vxhhz 10% eud kuxd ygu ypddy 3 kuxdd xy 103.;
Use of Proceeds
Qxjknrnzknc
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.